Which has the lower trailing P/E, DXCM or HUM?

DXCM has the lower trailing P/E: DXCM trades at 29.46 and HUM at 34.72. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DXCM or HUM?

Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus HUM at 12.61%.

Does DXCM or HUM pay a bigger dividend?

HUM pays a dividend (0.97% yield), while DXCM has no payments in the available dividend history.

Is DXCM or HUM more profitable?

DXCM runs the higher net margin — DXCM at 20.12% versus HUM at 0.88%.

How have DXCM and HUM total returns compared?

Over the past 10 years, DXCM delivered 12.45% and HUM delivered 8.74% annualized total return. Past performance doesn't predict future results.

DexCom, Inc. (DXCM) vs Humana Inc. (HUM)

A side-by-side comparison of DexCom, Inc. and Humana Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.

DXCM

DexCom, Inc.

$32.02B

$82.99HealthcareDelayed quote: Jul 31, 2026, 1:30 PM EDT

HUM

Humana Inc.

$44.12B

$367.47HealthcareDelayed quote: Jul 31, 2026, 1:29 PM EDT

Total return — DXCM vs HUM

growth of $100 · dividends reinvested · last 21y

DXCM +2435.4%HUM +1185.4%DXCM compounded faster

DXCM HUM

DXCM vs HUM: by the numbers

•HUM is the larger company ($44.12B vs $32.02B market cap).
•DXCM trades at the lower trailing earnings multiple (29.46 vs 34.72 P/E), one valuation lens rather than an overall verdict.
•DXCM converts more revenue to profit (20.12% vs 0.88% net margin).
•DXCM grew revenue faster over the past five years (18.03% vs 12.61% CAGR).
•HUM pays a dividend (0.97% yield), while DXCM has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	DXCM	HUM
P/E ratio	29.46	34.72
Forward P/E	28.75	40.78
P/S ratio	5.88	0.30
P/B ratio	11.14	2.31
PEG ratio	0.67	N/A
EV / EBITDA	23.22	17.71
FCF yield	4.81%	4.40%

Profitability

Metric	DXCM	HUM
Gross margin	62.79%	14.54%
Operating margin	22.92%	1.51%
Net margin	20.12%	0.88%
ROE	38.14%	6.66%
ROIC	16.61%	3.12%

Dividends

Metric	DXCM	HUM
Dividend yield	N/A	0.97%
Payout ratio	N/A	35.87%

Growth (annualized)

Metric	DXCM	HUM
Revenue CAGR (5Y)	18.03%	12.61%
EPS CAGR (5Y)	10.31%	-17.27%
FCF CAGR (5Y)	69.49%	-39.63%
Total return CAGR (5Y)	-10.37%	-1.98%

Frequently asked

Which has the lower trailing P/E, DXCM or HUM?: DXCM has the lower trailing P/E: DXCM trades at 29.46 and HUM at 34.72. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DXCM or HUM?: Over the past five years, DXCM grew revenue faster — DXCM at a 18.03% CAGR versus HUM at 12.61%.
Does DXCM or HUM pay a bigger dividend?: HUM pays a dividend (0.97% yield), while DXCM has no payments in the available dividend history.
Is DXCM or HUM more profitable?: DXCM runs the higher net margin — DXCM at 20.12% versus HUM at 0.88%.
How have DXCM and HUM total returns compared?: Over the past 10 years, DXCM delivered 12.45% and HUM delivered 8.74% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DXCM analysis Full HUM analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio Humana P/E ratio DexCom dividend yield Humana dividend yield DexCom ROE Humana ROE DexCom operating margin Humana operating margin DexCom revenue growth Humana revenue growth DexCom free cash flow Humana free cash flow

DexCom & Humana appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.